51
Views
33
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Protein Kinase C-Mediated Phosphorylation of the Leukemia-Associated HOXA9 Protein Impairs Its DNA Binding Ability and Induces Myeloid Differentiation

, , , , , & show all
Pages 3827-3837 | Received 30 Sep 2003, Accepted 05 Feb 2004, Published online: 27 Mar 2023

REFERENCES

  • Ausubel, F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and Struhl K. (ed.). 1987. Current protocols in molecular biology, p. 12.1.1–12.1.8. John Wiley & Sons, Hoboken, N.J.
  • Berry, M., and Gehring W.. 2000. Phosphorylation status of the SCR homeodomain determines its functional activity: essential role for protein phosphatase 2A,B′. EMBO J. 19:2946–2957.
  • Borrow, J., Shearman A. M., Stanton V. P. J., Becher R., Collins T., Williams A. J., Dube I., Katz F., Kwong Y. L., Morris C., Ohyashiki K., Toyama K., Rowley J., and Housman D. E.. 1996. The t(7;11)(p15;p15) translocation in acute myeloid leukemia fuses the genes for nucleoporin NU98 and class I homeoprotein HOXA9. Nat. Genet. 12:159–167.
  • Bourbon, H. M., Martin-Blanco E., Rosen D., and Kornberg T. B.. 1995. Phosphorylation of the Drosophila engrailed protein at a site outside its homeodomain enhances DNA binding. J. Biol. Chem. 270:11130–11139.
  • Boyle, W. J., van der Geer P., and Hunter T.. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–143.
  • Calvo, K. R., Knoepfler P. S., Sykes D. B., Pasillas M. P., and Kamps M. P.. 2001. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc. Natl. Acad. Sci. USA 98:13120–13125.
  • Calvo, K. R., Sykes D. B., Pasillas M., and Kamps M. P.. 2000. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced Meis expression. Mol. Cell. Biol. 20:3274–3285.
  • Calvo, K. R., Sykes D. B., Pasillas M. P., and Kamps M. P.. 2002. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene 21:4247–4256.
  • Coqueret, O., Berube G., and Nepveu A.. 1998. The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase. EMBO J. 17:4680–4694.
  • Coqueret, O., Martin N., Berube G., Rabbat M., Litchfield D. W., and Nepveu A.. 1998. DNA binding by cut homeodomain proteins is down-modulated by casein kinase II. J. Biol. Chem. 273:2561–2566.
  • Davies, S. P., Reddy H., Caivano M., and Cohen P.. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95–105.
  • Dong, J., Hung L. H., Strome R., and Krause H. M.. 1998. A phosphorylation site in the ftz homeodomain is required for activity. EMBO J. 17:2308–2318.
  • Dorsam, T. S., Ferrell M. C., Dorsam P. G., Vijapurkar U., Khodabakhsh D., Pau B., Bernstein H., Haqq M. C., Largman C., and Lawrence H. J.. 2004. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood 103:1676–1684.
  • Eklund, E. A., Jalava A., and Kakar R.. 2000. Tyrosine phosphorylation of HoxA10 decreases DNA binding and transcriptional repression during interferon gamma-induced differentiation of myeloid leukemia cell lines. J. Biol. Chem. 275:20117–20126.
  • Gehring, W. J. 1987. Homeo boxes in the study of development. Science 236:1245–1252.
  • Gehring, W. J., Qian Y. Q., Billeter M., Furukubo-Tokunaga K., Affolter M., Otting G., and Wuthrich K.. 1994. Homeodomain-DNA recognition. Cell 69:211–223.
  • Ghaffari, M., Zeng X., Whitsett J. A., and Yan C.. 1997. Nuclear localization domain of thyroid transcription factor-1 in respiratory epithelial cells. Biochem. J. 328:757–761.
  • Golub, T. R., Slonim D. K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J. P., Coller H., Loh M. L., Downing J. R., Caligiuri M. A., Bloomfield C. D., and Lander E. S.. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531–537.
  • Hall, M. N., Craik C., and Hiraoka Y.. 1990. Homeodomain of yeast repressor alpha 2 contains a nuclear localization signal. Proc. Natl. Acad. Sci. USA 87:6954–6958.
  • Izon, D. J., Komuves L. G., Rozenfeld S., Fong S., Largman C., and Lawrence H. J.. 1998. Loss of function of the homeobox gene HoxA-9 retards T-cell development and induces apoptosis. Blood 92:382–389.
  • Jaffe, L., Ryoo H.-D., and Mann R. S.. 1997. A role for phosphorylation by casein kinase II in modulating Antennapedia activity in Drosophila. Genes Dev. 11:1327–1340.
  • Kasahara, H., and Izumo S.. 1999. Identification of the in vivo casein kinase II phosphorylation site within the homeodomain of the cardiac tissue-specifying homeobox gene product Csx/Nkx2.5. Mol. Cell. Biol. 19:526–536.
  • Kissinger, C. R., Liu B., Martin-Blanco E., Kornberg T. B., and Pabo C. O.. 1990. Crystal structure of an engrailed homeodomain-DNA complex at 2.8 A resolution. A framework for understanding homeodomain-DNA interactions. Cell 63:579–590.
  • Kmita, M., and Duboule D.. 2003. Organizing axes in time and space; 25 years of colinear tinkering. Science 301:331–333.
  • Koeffler, H. P., Bar-Eli M., and Territo M. C.. 1981. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res. 41:919–926.
  • Kroon, E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A. M., and Sauvageau G.. 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17:3714–3725.
  • Kroon, E., Thorsteinsdottir U., Mayotte N., Nakamura T., and Sauvageau G.. 2001. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J. 20:350–361.
  • LaRonde-LeBlanc, N. A., and C. Wolberger. 2003. Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior. Genes Dev. 17:2060–2072.
  • Lawrence, H. J., Helgason C. D., Sauvageau G., Fong S., Izon D. J., Humphries R. K., and Largman C.. 1997. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922–1930.
  • Lawrence, H. J., Rozenfeld S., Cruz C., Matsukuma K., Kwong A., Komuves L., Buchberg A. M., and Largman C.. 1999. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13:1993–1999.
  • Lawrence, H. J., Sauvageau G., Humphries R. K., and Largman C.. 1996. The role of HOX genes in normal and leukemic hematopoiesis. Stem Cells 14:281–290.
  • Look, T. A. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059–1064.
  • Lotem, J., and Sachs L.. 1979. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc. Natl. Acad. Sci. USA 76:5158–5162.
  • Macfarlane, D. E., and Manzel L.. 1994. Activation of beta-isozyme of protein kinase C (PKC beta) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. Studies with PKC beta-defective PET mutant. J. Biol. Chem. 269:4327–4331.
  • Magli, M. C., Largman C., and Lawrence H. J.. 1997. Effects of HOX homeobox genes in blood cell differentiation. J. Cell Physiol. 173:168–177.
  • McGinnis, W., and Krumlauf R.. 1992. Homeobox genes and axial patterning. Cell 68:283–302.
  • Meisner, H., and Czech M. P.. 1991. Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II. Curr. Opin. Cell Biol. 3:474–483.
  • Mischak, H., Pierce J. H., Goodnight J., Kazanietz M. G., Blumberg P. M., and Mushinski J. F.. 1993. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. J. Biol. Chem. 268:20110–20115.
  • Moskow, J. J., Bullrich F., Huebner K., Daar I. O., and Buchberg A. M.. 1995. Meis, a PBX1-related homeobox gene involved in myeloid leukemias in BXH-2 mice. Mol. Cell. Biol. 15:5434–5443.
  • Muller, M., Affolter M., Leupin W., Otting G., Wuthrich K., and Gehring W. J.. 1988. Isolation and sequence-specific DNA binding of the Antennapedia homeodomain. EMBO J. 7:4299–4304.
  • Nakamura, T., Largaespada D. A., Lee M. P., Johnson L. A., Ohyashiki K., Toyama K., Chen S. J., Willman C. L., Chen I.-M., Feinberg A. P., Jenkins N. A., Copeland N. G., and Shaughnessy J. D. J.. 1996. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;15) in human myeloid leukemia. Nat. Genet. 12:154–158.
  • Naviaux, R. K., Costanzi E., Haas M., and Verma I. M.. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701–5705.
  • Niedel, J. E., Kuhn L. J., and Vandenbark G. R.. 1983. Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. USA 80:36–40.
  • Oshevski, S., Le Bousse-Kerdiles M. C., Clay D., Levashova Z., Debili N., Vitral N., Jasmin C., and Castagna M.. 1999. Differential expression of protein kinase C isoform transcripts in human hematopoietic progenitors undergoing differentiation. Biochem. Biophys. Res. Commun. 263:603–609.
  • Pinna, L. A. 1990. Casein kinase 2: an 'eminence grise' in cellular regulation? Biochim. Biophys. Acta 1054:267–284.
  • Rovera, G., Ferrero D., Pagliardi G. L., Vartikar J., Pessano S., Bottero L., Abraham S., and Lebman D.. 1982. Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action. Ann. N. Y. Acad. Sci. 397:211–220.
  • Schnabel, C. A., Jacobs Y., and Cleary M. L.. 2000. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene 19:608–616.
  • Senderowicz, L., Wang J. X., Wang L. Y., Yoshizawa S., Kavanaugh W. M., and Turck C. W.. 1997. 3-Phosphohistidine cannot replace phosphotyrosine in high-affinity binding to phosphotyrosine binding or Src homology 2 domains. Biochemistry 36:10538–10544.
  • Shen, W.-F., Montgomery J. C., Rozenfeld S., Lawrence H. J., Buchberg A., and Largman C.. 1997. The Abd-B-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol. Cell. Biol. 17:6448–6458.
  • Shen, W.-F., Rozenfeld S., Lawrence H. J., and Largman C.. 1997. The Abd-B-like Hox homeodomain proteins can be subdivided by the ability to form complexes with Pbx1a on a novel DNA target. J. Biol. Chem. 272:8198–8206.
  • Shen, W. F., Rozenfeld S., Kwong A., Komuves L., Lawrence H. J., and Largman C.. 1999. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol. Cell. Biol. 19:3051–3061.
  • Sock, E., Enderich J., Rosenfeld M. G., and Wegner M.. 1996. Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J. Biol. Chem. 271:17512–17518.
  • Steube, K. G., and Drexler H. G.. 1993. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1. Leuk Lymphoma 9:141–148.
  • Thorsteinsdottir, U., Kroon E., Jerome L., Blasi F., and Sauvageau G.. 2001. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol. Cell. Biol. 21:224–234.
  • Thorsteinsdottir, U., Krosl J., Kroon E., Haman A., Hoang T., and Sauvageau G.. 1999. The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol. Cell. Biol. 19:6355–6366.
  • Thorsteinsdottir, U., Mamo A., Kroon E., Jerome L., Bijl J., Lawrence H. J., Humphries K., and Sauvageau G.. 2002. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99:121–129.
  • Tuazon, P. T., and Traugh J. A.. 1991. Casein kinase I and II—multipotential serine protein kinases: structure, function, and regulation. Adv. Second Messenger Phosphoprotein Res. 23:123–164.
  • Tucker, K. A., Lilly M. B., Heck L., Jr., and Rado T. A.. 1987. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70:372–378.
  • Vandenbark, G. R., Kuhn L. J., and Niedel J. E.. 1984. Possible mechanism of phorbol diester-induced maturation of human promyelocytic leukemia cells. J. Clin. Investig. 73:448–457.
  • Ways, D. K., Messer B. R., Garris T. O., Qin W., Cook P. P., and Parker P. J.. 1992. Modulation of protein kinase C-epsilon by phorbol esters in the monoblastoid U937 cell. Cancer Res. 52:5604–5609.
  • Wolberger, C., Vershon A. K., Liu B., Johnson A. D., and Pabo C. O.. 1991. Crystal structure of a MATα2 homeodomain-operator complex suggests a general model for homeodomain-DNA interactions. Cell 67:517–528.
  • Yaron, Y., McAdara J. K., Lynch M., Hughes E., and Gasson J. C.. 2001. Identification of novel functional regions important for the activity of HOXB7 in mammalian cells. J. Immunol. 166:5058–5067.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.